The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
3-((1r,3r)-3-(4-chlorophenyl)cyclobutyl)-5-((7-methyl-6-oxo-6,7-dihydro-1H-purin-1-yl)methyl)-1,3,4-oxadiazol-2(3H)-one ID: ALA4865298
PubChem CID: 134540749
Max Phase: Preclinical
Molecular Formula: C19H17ClN6O3
Molecular Weight: 412.84
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cn1cnc2ncn(Cc3nn([C@H]4C[C@H](c5ccc(Cl)cc5)C4)c(=O)o3)c(=O)c21
Standard InChI: InChI=1S/C19H17ClN6O3/c1-24-9-21-17-16(24)18(27)25(10-22-17)8-15-23-26(19(28)29-15)14-6-12(7-14)11-2-4-13(20)5-3-11/h2-5,9-10,12,14H,6-8H2,1H3/t12-,14-
Standard InChI Key: CYWFSLKYTRCPPA-MQMHXKEQSA-N
Molfile:
RDKit 2D
29 33 0 0 0 0 0 0 0 0999 V2000
29.7199 -13.3171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.4337 -12.9036 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
30.4309 -12.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.7181 -11.6715 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.0077 -12.9040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.0044 -12.0834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2227 -11.8342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.7454 -12.5009 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2281 -13.1635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.7197 -14.1384 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
27.9787 -13.9459 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1462 -13.3152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8574 -12.9013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.6067 -13.2314 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.1526 -12.6191 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7429 -11.9078 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9397 -12.0791 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.0740 -11.1566 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.9696 -12.7032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.4842 -13.3401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.1226 -12.8207 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6032 -12.1824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.9396 -12.9049 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2701 -13.6541 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0862 -13.7385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5705 -13.0721 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2287 -12.3233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4135 -12.2383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.3876 -13.1593 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
5 1 1 0
1 2 1 0
2 3 1 0
3 4 2 0
4 6 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 5 1 0
1 10 2 0
9 11 1 0
2 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 1 0
16 17 1 0
17 13 1 0
16 18 2 0
19 15 1 6
19 20 1 0
20 21 1 0
21 22 1 0
22 19 1 0
21 23 1 1
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
26 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 412.84Molecular Weight (Monoisotopic): 412.1051AlogP: 2.10#Rotatable Bonds: 4Polar Surface Area: 100.74Molecular Species: NEUTRALHBA: 9HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.24CX LogD: 2.24Aromatic Rings: 4Heavy Atoms: 29QED Weighted: 0.51Np Likeness Score: -0.82
References 1. Villemure E, Terrett JA, Larouche-Gauthier R, Déry M, Chen H, Reese RM, Shields SD, Chen J, Magnuson S, Volgraf M.. (2021) A Retrospective Look at the Impact of Binding Site Environment on the Optimization of TRPA1 Antagonists., 12 (8.0): [PMID:34413952 ] [10.1021/acsmedchemlett.1c00305 ]